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Background 
• AChE is a serine protease that breaks 
down the neurotransmitter acetylcholine  
to terminate  neurotransmission.  
• AChE is present in all nerve synapses, 
neuromuscular junctions, and RBCs.  
• OPs are commonly found oil additives, 
pesticides, and chemical weapons, which 
can target and inhibit AChE. 
 
 
 
 
 
 
 
 
 
• Acute cholinergic crisis, is the major 
manifestation of OP poisoning.  Inhibition 
of synaptic AChE causes an accumulation 
of acetylcholine in the nerve synapse 
leading to continuous neurotransmission 
and possible death within minutes. 
• Molecular Dynamic (MD) analysis was 
performed to elucidate characteristics of 
enzyme/adduct to aid design of more 
effective countermeasures of OP poisoning. 
Results and Conclusions 
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Figure 1. Proposed mechanism for irreversible “aging” of AChE by an OP. 
Figure 5. Side Entrance to Active Site 
of Apoprotein. In orange, side door 
opening. In blue, main gorge closed. In 
yellow, catalytic triad of active site. 
Figure 4.  Entrance to Active Site of 
Apoprotein. In blue, main gorge 
opening. In yellow, catalytic triad of 
active site.  
Table 1. Root-Mean Square Inner Product (RMSIP) calculations 
comparing non-adducted simulation to OP-adducted 
simulations. 
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Figure 2. Beginning structure of apoprotein 
simulation colored by secondary structure. 
Figure 3. Beginning Structure of soman-
adducted simulation colored by secondary 
structure. 
  APO-AChE Soman-AChE 
APO-AChE 0.628 0.362 
Soman-AChE 0.527 
Figure 6. Main door opening in 
soman-adducted simulation. In blue, 
isolated residues of main door. In 
yellow, catalytic triad of active site. 
Figure 7 .  Distance plot across gorge 
of apoprotein simulation reveals more 
drastic  gorge fluctuations, supported 
by visual observation of principle 
modes of movement.  
Figure 8.  Distance plot across gorge 
of adducted simulation reveals rigid  
gorge fluctuations., supported by visual 
observation of principle modes of 
movement. 
Abstract 
Acetylcholinesterase (AChE) is a target enzyme of 
organophosphate (OP). Current treatments for OP 
poisoning, i.e. oximes, have limited success, especially 
without pre-treatment. This study uses molecular 
dynamic analysis to shine light on structure and 
dynamical fluctuations of free AChE and OP-inhibited 
AChE. Knowledge gained by the study of OP inhibition 
of acetylcholinesterase should guide future drug 
designs of more effective antitoxins. 
Methods 
NAMD, Scalable Molecular 
Dynamics: Parallel  molecular 
dynamics code for high-
performance simulation 
1 
Essential Dynamics Analysis: 
Covariance matrix of 
positional fluctuations of the 
Ca atoms analyzed reveal 
principle directions of large 
concerted motions used to 
assess dynamical similarity 
2 
VMD, Visual Molecular 
Dynamics: displaying, 
animating and analyzing 
biomolecular systems (Solvent 
Accessible Surface Area, 
Distance Plots, Modes of 
Motion Comparison) 
3 
MOLE: Rapid and fully 
automated location and 
characterization of channels, 
tunnels, and pores in 
molecular structures 
4 
• Minimal conformational 
differences between initial 
structures of simulations.  
• Simulations adequately 
sampled essential subspace. 
Apoprotein simulation 
compared with soman-
adducted simulation show 
low similarity of overall 
motions. 
• Adducted simulation revealed more 
rigid fluctuations when compared 
with apoprotein. 
•  Side door to active site revealed in 
both apoprotein and adducted 
simulations. 
1 
2 
3 
• MOLE analysis 
reveals side doors 
open while main 
gorge is closed 
and also suggests 
gorge volume is 
not necessarily 
correlated with 
main door 
configuration. 
Figure 9. Tunnel predicted by 
MOLE corresponds to main gorge 
in apoprotein. Cavity (green) 
volume: 483 A3 
Figure 10. Tunnel predicted by 
MOLE reveals opened side door in 
apoprotein. Cavity (green) 
volume: 704 A3 
Figure 11. Tunnel predicted by 
MOLE corresponds to main gorge 
in adducted protein. Cavity (green) 
volume: 483 A3 
Figure 12. Tunnels predicted by 
MOLE reveal opened side and back 
doors while main gorge opening is 
closed in adducted protein. Cavity 
(green) volume: 1351 A3 
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